| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |